Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 27;11(6):004627.
doi: 10.12890/2024_004627. eCollection 2024.

A Silent Cause of Shock: Autoimmune Polyglandular Syndromes

Affiliations

A Silent Cause of Shock: Autoimmune Polyglandular Syndromes

Mark A Colantonio et al. Eur J Case Rep Intern Med. .

Abstract

Addison's disease is a rare, autoimmune condition leading to destruction of the adrenal gland. Autoimmune conditions are known to commonly co-occur. When Addison's disease presents in the setting of autoimmune thyroid disease and/or type 1 diabetes, this condition is termed autoimmune polyendocrine syndrome type II, a rare endocrinopathy found in roughly 1.4-4.5 per 100,000 individuals. Here, we describe a clinical case presenting with hypotension refractory to fluid resuscitation and electrolyte derangements later diagnosed as autoimmune polyendocrine syndrome type II.

Learning points: Primary adrenal insufficiency may present clinically as shock refractory to fluid resuscitation.Autoimmune polyglandular syndrome type 2 is a rare autoimmune condition occurring in 1.5-4.5 per 100,000 individuals.The presence of an underlying autoimmune condition should raise suspicion for multiple concurrent autoimmune conditions.

Keywords: Addison’s disease; Adrenal insufficiency; Hashimoto’s disease; autoimmune polyendocrine syndrome type 2; autoimmune polyglandular syndromes.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interests: Each author certifies that he/she, a member of his or her immediate family, has no commercial association (i.e., consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted manuscript. The authors have not used generative artificial intelligence or artificial intelligence associated technologies.

Similar articles

Cited by

  • Thyroxine Reveals Addison's Disease: A Case Report.
    Tsinopoulou VR, Kolanis S, Katsarou D, Kotanidou EP, Galli-Tsinopoulou A. Tsinopoulou VR, et al. Cureus. 2025 Jun 18;17(6):e86299. doi: 10.7759/cureus.86299. eCollection 2025 Jun. Cureus. 2025. PMID: 40688962 Free PMC article.

References

    1. Anaya JM, Shoenfeld Y, Rojas-Villarraga A, Levy RA, Cervera R. Autoimmunity: from bench to bedside. First edition. Bogota, Colombia: Center for Autoimmune Diseases Research, School of Medicine and Health Sciences, El Rosario University; 2013. - PubMed
    1. Huecker MR, Bhutta BS, Dominique E. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2024. Adrenal Insufficiency. [cited 2024 May 10]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK441832/ - PubMed
    1. Michels A, Michels N. Addison disease: early detection and treatment principles. Am Fam Physician. 2014;89:563–568. - PubMed
    1. Alexandraki KI, Grossman A. Diagnosis and Management of Adrenal Insufficiency. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al., editors. Endotext [Internet] South Dartmouth (MA): MDText.com, Inc; 2000. [cited 2024 May 10]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK279122/
    1. Burke CW. Adrenocortical insufficiency. Clin Endocrinol Metab. 1985 Nov;14(4):947–76. - PubMed

LinkOut - more resources